Talphera (TLPH) FCF Margin Growth (1y) (2012 - 2023)
Talphera (TLPH) FCF Margin Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 97,354.00 |
| Mar 31, 2022 | -13,690.00 |
| Dec 31, 2021 | -40.05 Mn |
| Sep 30, 2021 | 35,504.00 |
| Jun 30, 2021 | -190,863.00 |
| Mar 31, 2021 | 183,565.00 |
| Dec 31, 2020 | 195,263.00 |
| Sep 30, 2020 | 152,456.00 |
| Jun 30, 2020 | 109,472.00 |
| Mar 31, 2020 | 150,437.00 |
| Dec 31, 2019 | -152,426.00 |
| Sep 30, 2019 | -40,168.00 |
| Jun 30, 2019 | -62,394.00 |
| Mar 31, 2019 | -303,403.00 |
| Dec 31, 2018 | -61,669.00 |
| Sep 30, 2018 | -122,856.00 |
| Jun 30, 2018 | -42,209.00 |
| Mar 31, 2018 | -195,089.00 |
| Dec 31, 2017 | -70,113.00 |
| Sep 30, 2017 | -30,835.00 |